What is Neurotech?
Neurotech specializes in providing comprehensive EEG monitoring solutions, catering to both in-home and hospital environments. Established in 2006, the company offers continuous EEG monitoring, including ambulatory options with or without video capabilities. Neurotech also plays a crucial role in supporting clinical research by facilitating in-home EEG setups for trials, thereby ensuring timely and accurate diagnoses of neurological disorders across diverse patient settings. Their commitment extends to community support and employee empowerment, aiming for positive societal contributions.
How much funding has Neurotech raised?
Neurotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Neurotech?
With its recent substantial backing and a clear focus on scaling operations, Neurotech is strategically positioned for accelerated growth. The company's late-stage funding context suggests a move towards market consolidation, potential expansion into new geographical regions, or the development of advanced diagnostic technologies. This infusion of capital will likely enable Neurotech to enhance its service offerings, broaden its reach within the healthcare ecosystem, and solidify its leadership in continuous EEG monitoring.
See full Neurotech company page
